LighthouseAI, a provider of a central intelligence and management platform for pharmaceutical state licensing and compliance, raised an $8 million in a Series A funding round led by Boxcars Ventures, with participation from TGVP and existing investors.
Series A funds will be directed primarily toward delivery improvements, product development, and service expansion in support of the expected growth trajectory.
The Los Angeles, California-based startup has doubled its customer base since January 2025 and now serves 250 customers across the pharmaceutical supply chain, including manufacturers, wholesale distributors, third-party logistics providers, 503B outsourcing facilities, pharmacies, and repackagers.
In 2025, LighthouseAI processed change-of-ownership transactions for companies representing more than $12 billion in combined revenue.
LighthouseAI said it has achieved profitability in Q4 2025. Today, the startup serves more than 15 enterprises customers with over $1 billion in annual revenue.
“We are proud of what our team has built and the trust our customers have placed in us,” said Sumeet Singh, Founder and CEO of LighthouseAI. “This funding allows us to continue the growth we’ve worked for. We are grateful for the dedication of our employees and the loyalty of our customers.”
Digital health companies, including pharmaceutical compliance software startups, have secured more than $180 billion in funding to date, according to our recent Funding Database. More recently, Keebler Health, a clinical documentation startup, raised $16 million in a Series A funding round to accelerate commercial growth in the U.S.
In another deal, AcuityMD, a provider of a data-driven sales enablement platform designed specifically for the medical technology (MedTech) industry, raised $80 million in a new Series C funding round to advance its platform with cutting-edge artificial intelligence (AI) capabilities and drive the adoption of its medical technology platform.